Most of stable patients have the wrong idea about the purpose of PCI

Original title: Variation in patients’ perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study. Referencia: Kureshi F et al. BMJ. 2014;Epub ahead of print.

This study included 991 consecutive patients with stable coronary disease undergoing elective PCI in 10 university and community centers between 2009 and 2011. After procedure, patients were asked a series of questions about their perception of the urgency and benefits of PCI. 44% had had a previous intervention and 85% were symptomatic with angina or dyspnea.

90% of the population reported PCI would prolong their lives, 88% reported it would prevent eventual infarctions and 20% reported it was an emergency procedure, despite the fact that all of them were elective. Only 1% of patients reported that the only benefit expected from this procedure was the relief of symptoms.

Some interesting characteristics of patients influenced their perception of PCI. The youngest most frequently believed that PCI could save their lives, in addition to the prevention of infarction and symptoms relief. Married patients, as opposed to single ones, also exaggerated the benefits of PCI and those less educated were more frequently inclined to think PCI was an emergency procedure. However, not only did these characteristics influence patients’ opinions, but also operators’ opinions. Patients undergoing PCI handled by more experienced elder cardiologists were more often convinced that PCI would prolong their lives. Another issue that influenced outcomes was whether consent was obtained by the operator himself, by a fellow or by a nurse.

Conclusion

Most of patients undergoing elective PCI have little information about the risks and benefits of this procedure. 

Editorial Comment

The moment patients sign the informed consent form is their last opportunity to make questions and inform themselves about the risks and benefits of this procedure, and this is why professionals in charge (operator, fellow or nurse) must be able to answer any question that may arise. Explicitly writing objective figures about possible complications or benefits is no simple task and may turn out to be rather uncomfortable for many patients and doctors.

SOLACI

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....